Clinical trial
Prediction of Response to Treatment of Patients With Chronic HCV Infection by…
NCT00272389 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00272389 |
|---|---|
| Title | Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile |
| Official title | Prediction of Response to PEGINTERFERON and RIBAVIRIN Treatment in Patients With Chronic HCV Infection by Genetic Profile |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Hepatitis C Virus Chronic Infection |
| Enrollment | 150 |
| Start date | Mar 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jan 6, 2006 |
| Last update posted | Jan 6, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: